Please write a SOAP note for a 27-year-old woman presenting with acute bacterial vaginosis (BV) causing 3‑day vaginal itching, thin gray‑white discharge, fishy odor, vaginal pH 5.5, and clue cells on wet mount, with no other symptoms.

SOAP Note for Acute Bacterial Vaginosis

Subjective

Chief Complaint: 27-year-old woman presenting with 3 days of vaginal itching, discharge, and odor.

History of Present Illness:

• Duration: 3 days
• Vaginal discharge: Thin, gray-white, homogeneous
• Odor: Fishy smell
• Associated symptoms: Vaginal itching
• Negative symptoms: No dysuria, no dyspareunia, no abdominal pain, no fever

Sexual History:

• Sexual activity status (document number of partners, new partners, condom use)
• Last menstrual period
• Contraception method

Past Medical History:

• Previous episodes of vaginitis
• History of sexually transmitted infections
• Pregnancy history

Medications: Current medications, recent antibiotic use

Allergies: Medication allergies (particularly metronidazole, clindamycin)

Objective

Vital Signs: Within normal limits

Physical Examination:

• External genitalia: No vulvar erythema or lesions
• Speculum examination:
  • Thin, gray-white, homogeneous discharge coating vaginal walls
  • No cervical erythema or petechiae
  • No cervical motion tenderness

Laboratory Findings:

• Vaginal pH: 5.5 (elevated; normal <4.5)
• Wet mount microscopy: Clue cells present
• Whiff test: Not documented (would be positive with fishy odor after KOH application)
• Amsel criteria met: 3 of 4 criteria present (homogeneous discharge, elevated pH >4.5, clue cells) 1, 2

Assessment

Primary Diagnosis: Bacterial vaginosis (BV)

Diagnostic Reasoning: Patient meets clinical diagnostic criteria for BV using Amsel criteria, requiring 3 of 4 findings: homogeneous white discharge coating vaginal walls, vaginal pH >4.5, clue cells on microscopy, and fishy odor 1, 2, 3. This patient has documented thin gray-white discharge, pH 5.5, and clue cells present.

Plan

Treatment

First-line therapy: Metronidazole 500 mg orally twice daily for 7 days 1, 2, 3

This oral regimen achieves 95% cure rates and is the CDC-recommended first-line treatment for symptomatic BV 1.

Alternative regimens (if patient cannot tolerate oral metronidazole):

• Metronidazole gel 0.75%, one full applicator (5g) intravaginally twice daily for 5 days 1, 2
• Clindamycin cream 2%, one full applicator (5g) intravaginally at bedtime for 7 days 1, 2

Important counseling points:

• Avoid alcohol during metronidazole treatment and for 24 hours after completion to prevent disulfiram-like reaction 1
• Complete entire course even if symptoms resolve
• Clindamycin cream is oil-based and may weaken latex condoms and diaphragms 2

Partner Management

No partner treatment required - Treatment of male sex partners has not been shown to influence response to therapy or reduce recurrence rates 1, 2. Routine partner treatment is not recommended 1.

Follow-up

No routine follow-up visit necessary if symptoms resolve 1. Instruct patient to return if:

• Symptoms persist after completing treatment
• Symptoms recur (recurrence is common with BV) 1

Additional Considerations

• Recurrent BV: If patient experiences recurrence, can retreat with same regimen or alternative regimens 1. For documented multiple recurrences, longer courses of therapy are recommended 3
• STI screening: Consider testing for other sexually transmitted infections (chlamydia, gonorrhea, HIV, syphilis) based on sexual history and risk factors 4
• Pregnancy status: Confirm not pregnant; if pregnant, treatment approach differs (clindamycin cream preferred in first trimester) 1

Patient Education

• BV is not considered exclusively a sexually transmitted disease, though it is associated with sexual activity 1
• Recurrence occurs in up to 50% of women within one year 5, 6
• Avoid douching and use of irritating vaginal products
• Return for evaluation if symptoms persist or recur